tirzepatide 2024 Semaglutide and treatment leads to weight loss in type 1 diabetes Republican Administration Maintains Exclusivity Stance

[DOI] [PubMed] [Google Scholar] 46.Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, et al

Tirzepatide versus dulaglutide Among patients in the expanded population who initiated tirzepatide or dulaglutide, the 1-year risk for the primary endpoint including all-cause mortality in the tirzepatide group was 1.4% (95% CI 1.3% to 1.6%) versus 1.8% (95% CI 1.5% to 2.0%) for dulaglutide

The team at Mochi Health is here to help

Injections are taken under the skin in the stomach, upper thigh or upper arm

Better blood sugar control reduces energy crashes and sugar cravings that often derail weight loss efforts

Time your injection strategically